Related Experiment Video
Updated: Feb 15, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
Subclinical Primary Aldosteronism and eGFR Decline Over Time
Gregory L Hundemer1,2, Louis-Charles Desbiens3, Mohsen Agharazii4,5
1Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Subclinical primary aldosteronism, indicated by elevated aldosterone-to-renin ratio (ARR), is linked to faster kidney function decline. Lower renin levels also correlate with increased estimated glomerular filtration rate (eGFR) decline, independent of blood pressure.
Area of Science:
- Nephrology
- Endocrinology
- Cardiovascular Research
Background:
- Primary aldosteronism accelerates kidney function decline.
- Subclinical forms of primary aldosteronism are common but their impact on kidney function is unknown.
Purpose of the Study:
- To investigate the association between subclinical primary aldosteronism markers and estimated glomerular filtration rate (eGFR) decline.
Main Methods:
- Prospective cohort study of 976 Canadian adults (40-69 years).
- Measured aldosterone, renin, creatinine, and cystatin C.
- Used multivariable linear mixed regression to assess associations of aldosterone, renin, and aldosterone-to-renin ratio (ARR) with eGFR decline over 5-7 years.
Main Results:
- Higher ARR was associated with a 11% steeper eGFR decline over time.
- Lower renin levels were associated with a 16% steeper eGFR decline over time.
- Aldosterone alone showed no significant association with eGFR change.
Conclusions:
- Elevated ARR and suppressed renin are independently associated with accelerated eGFR decline.
- These associations persist regardless of blood pressure levels.
Related Concept Videos
Magnetic Declination
Conservation of Declining Populations
Primary Active Transport
Primary and Secondary Growth in Roots and Shoots
Primary Production
Primary Distribution

